BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil ...
Common side effects include nausea, trouble sleeping, aggression, diarrhea, feeling tired, and muscle cramps. Donepezil was approved for medical use in the United States in There is no evidence that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results